NMR Studies of Ganglioside and AB Peptide Interactions

About the Research Project
Program
Award Type
Standard
Award Amount
$100,000
Active Dates
April 01, 2004 - September 30, 2006
Grant ID
A2004267
Summary
Amyloid plaques and tangled bundles of fiber (neurofibrillary tangles or NFTs) are thought to play an important role in the pathogenesis of Alzheimer’s disease (AD). Scientists have found that the amyloid plaques are associated with a type of molecule called gangliosides in the brains of Alzheimer’s patients. There are five main gangliosides in the human brain, and research shows that some gangliosides increase while others decrease with aging. Dr. Mandal has already demonstrated through nuclear magnetic resonance (NMR) studies that one ganglioside is capable of preventing the toxic precipitant in an experimental environment. His current goal is to understand the role of these “good” and “bad” gangliosides in the formation of toxic amyloid plaques. This research could lead to the design of new drugs that could slow or halt the symptoms of AD and could also contribute to the development of a noninvasive way to test for Alzheimer’s disease using magnetic resonance spectroscopy.
Grants
Related Grants
Alzheimer's Disease Research
Regulatory Mechanisms Underlying Endosomal Targeting of SORL1
Active Dates
January 01, 2025 - December 31, 2026
Principal Investigator
Olav Andersen, PhD
Current Organization
Max Delbrück Center for Molecular Medicine
Regulatory Mechanisms Underlying Endosomal Targeting of SORL1
Active Dates
January 01, 2025 - December 31, 2026

Principal Investigator
Olav Andersen, PhD
Current Organization
Max Delbrück Center for Molecular Medicine
Alzheimer's Disease Research
The Role of DYRK1A in Altered Microglia Biology in a Cellular Model of Alzheimer’s Disease in Down Syndrome
Active Dates
January 01, 2025 - December 31, 2027
Principal Investigator
Frances Wiseman, PhD
Current Organization
University College London (UK)
The Role of DYRK1A in Altered Microglia Biology in a Cellular Model of Alzheimer’s Disease in Down Syndrome
Active Dates
January 01, 2025 - December 31, 2027

Principal Investigator
Frances Wiseman, PhD
Current Organization
University College London (UK)
Alzheimer's Disease Research
Synergistic Effects of Biological Sex and Sleep Loss in an AD Mouse Model
Active Dates
January 01, 2025 - December 31, 2026
Principal Investigator
Mallar Chakravarty, PhD
Current Organization
Douglas Research Centre
Synergistic Effects of Biological Sex and Sleep Loss in an AD Mouse Model
Active Dates
January 01, 2025 - December 31, 2026
Principal Investigator
Mallar Chakravarty, PhD
Current Organization
Douglas Research Centre